CCL2 and neoplasm: This finding was backed up in a murine in vivo model of experimental lung metastases, where subcutaneous administration of CCL2-transfected fibroblasts along with RENCA cells (and subsequent administration of transfected fibroblasts at days 3, 5, and 7 into the original site of injection) reduced tumor size and amount of metastasis to the lung (129).